- Nachrichtendetail
-
01.04.2024 02:34:39 - dpa-AFX: *EISAI COMPLETES SUBMISSION OF LEQEMBI SBLA FOR IV MAINTENANCE DOSING FOR TREATMENT OF EARLY ALZHEIMER'S DISEASE TO FDA
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
BIOGEN INC. DL -,0005 | 789617 | Xetra | 214,900 | 06.06.24 14:49:57 | -0,800 | -0,37% | 216,000 | 217,600 | 217,900 | 215,700 |
